Umbilical cord mesenchymal stem cell therapy (Hebei Medical University)

N/A

Report date: 2023/03/03 20:00:36

Base Information

Drug NameUmbilical cord mesenchymal stem cell therapy (Hebei Medical University)

Drug Alias NameUmbilical cord mesenchymal stem cells implantation(Hebei Medical University)

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesHebei Medical University

China Registration ClassN/A

Develop Information

Active CompaniesHebei Medical University

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A